Inhibition of Transcription factor NFkB by methionine-redox
Inhibition of Transcription factor NFkB by methionine-redox
批准号:
15380088
负责人:
MIYAMOTO Yusei
金额:
$10.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2006
中文摘要
中性粒细胞是白细胞中的一种,在宿主防御细菌感染中起着重要作用。当中性粒细胞吞噬入侵细菌时,髓过氧化物酶(MPO)介导过氧化氢和氯离子产生次氯酸(HClO)。盐酸是一种强氧化剂,能杀死被吞噬的细菌。在中性粒细胞中,牛磺酸是最丰富的游离氨基酸。牛磺酸似乎有助于保护中性粒细胞免受HClO的侵害,因为牛磺酸与HClO立即反应,形成牛磺酸氯胺(TauCl),其毒性远低于HClO。然而,TauCl的进一步生物活性尚不清楚。当中性粒细胞吞噬入侵细菌时,核因子κB (NFκB)被激活。NFκB是炎症的重要转录因子之一。在本研究项目中,我们研究了TauCl与NFκB活化的相互作用。NFκB存在于细胞质中,作为一种无活性的三级复合体与抑制蛋白称为i - κ b。刺激后,i - κ b被蛋白酶体磷酸化和降解,导致nf - κ b活化。TauCl在蛋氨酸45处氧化i - κ b (1 - κ3α)的a型异构体形成亚砜,抑制其蛋白酶体依赖性降解。这种抑制抑制了nf - κ b的激活,导致中性粒细胞中nf - κ b依赖性炎症细胞因子如白细胞介素8的产生。这是牛磺酸抗炎活性的分子机制之一。嗜酸性粒细胞在肺部的募集和随后的积累发生在许多炎症性疾病中,包括哮喘。以前的研究报告说牛磺酸可以减轻哮喘发作。在嗜酸性粒细胞中,存在嗜酸性过氧化物酶(EPO),而不是MPO和产生次溴酸(HBrO)来攻击微生物。牛磺酸与HBrO反应生成牛磺酸溴(TauBr)。我们检查了TauBr是否像TauCl一样抑制NFκB的激活。与TauCl类似,TauBr抑制NFκB活化。此外,TauBr比TauCl具有更高的膜通透性,这表明TauBr可能抑制气道中促炎介质的产生。通常认为牛磺酸具有防止细胞凋亡的功能。中性粒细胞消灭细菌后,易发生细胞凋亡。由于活化NFκB可阻止细胞凋亡,TauCl可能通过抑制NFκB促进细胞凋亡。TauCl通过抑制NFκB来减弱FLICE抑制蛋白短形式的表达。此外,TauCl激活了cJun n末端激酶。这些数据表明TauCl通过两种独立的细胞信号启动中性粒细胞的凋亡。少
英文摘要
Neutrophils are one of the white blood cells that have an important role in the host defense against bacterial infection. When neutrophils phagocytose invading bacteria, myeloperoxidase (MPO) mediates production of hypochlorous acid (HClO) from hydrogen peroxide and chloride ion. HClO is a strong oxidant kills phagocytosed bacteria. In neutrophils, taurine is the most abundant free amino acid. Taurine seems to help protect neutrophils against HClO, because taurine instantaneously reacts with HClO and forms taurine chloramine (TauCl) that is by far less toxic than HClO. However, the further biological activity of TauCl has been left unclear.When neutrophils phagocytose invading bacteria, nuclear factor kappa B (NFκB) is activated. NFκB is one of the crucial transcription factors in inflammation. In this research program, we studied interaction of TauCl with NFκB activation. NFκB is present in the cytoplasm as an inactive tertiary complex with inhibitory proteins known as IκBs. Upon stim … More uli, IκB is phosphorylated and degraded by proteasome, leading to activation of NFκB. TauCl oxidized the a isoform of IκB (1κ3α) at methionine 45 to form sulphoxide and inhibited its proteasome-dependent degradation. This inhibition suppressed the activation of NFκB, leading to NFκB-dependent production of inflammatory cytokines like interleukin 8 in neutrophil. This is one of the molecular mechanisms of anti-inflammatory activation of taurine.The recruitment and subsequent accumulation of eosinophils in the lung occur in a number of inflammatory disorders, including asthma. Previous studies reported that taurine mitigates asthma attack. In eosinophils, eosinophil peroxidase (EPO) is present, instead of MPO and hypobromous acid (HBrO) is produced to attack microorganisms. Taurine reacts with HBrO to form taurine bromamine (TauBr). We examined if TauBr suppresses NFκB activation like TauCl. TauBr inhibited NFκB activation similarly to TauCl. Furthermore, TauBr has higher membrane permeability than TauCl, suggesting that TauBr may suppress production of proinflammatory mediators in the airway.It is usually said that taurine functions for cell protection against apoptosis. After neutrophils eliminate bacteria, they are susceptible to apoptosis. Since NFκB activation prevents apoptosis, TauCl may promote apoptosis by inhibition of NFκB. TauCl attenuated expression of FLICE inhibitory protein short form via inhibition of NFκB. Furthermore, TauCl activated cJun N-terminal kinase. These data indicate that TauCl initiates apoptosis of neutrophils via two independent cell signals. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Taurine is involved in oxidation of IκBα at Met45
牛磺酸参与 IκBα Met45 的氧化
DOI:
--
发表时间:
2003
期刊:
Advances in Experimental Medicine and Biology 526(Taurine5)
影响因子:
--
作者:
[Yusei Miyamoto, Atsuhiro Kanayama, Jun-lchiro Inoue, Yoshiko Sugita-Konishi, Makoto Shimizu]
通讯作者:
Makoto Shimizu
Modification of IKBcL by taurine bromamirn inhibits tumor necrosis factor α-induced NF-κB activation.
牛磺酸 bromamirn 对 IKBcL 的修饰可抑制肿瘤坏死因子 α 诱导的 NF-κB 激活。
DOI:
--
发表时间:
2007
期刊:
Inflammation Research (in press)
影响因子:
--
作者:
[Saimi Tokunaga, Atsuhiro Kanayama Yusiro Miyamoto.]
通讯作者:
Atsuhiro Kanayama Yusiro Miyamoto.
Modification of IκBα by taurine bromamine inhibits tumornecrosis factor α-induced NF-κB activation
牛磺酸溴胺修饰 IκBα 抑制肿瘤坏死因子 α 诱导的 NF-κB 激活
DOI:
--
发表时间:
2007
期刊:
Inflammation Research (in press)
影响因子:
--
作者:
[Saimi Tokunaga, Atsuhiro Kanayama, Yusei Miyamoto]
通讯作者:
Yusei Miyamoto
Apoptosis by phagocytosis-related oxidative stress through FLIPs down-regulation and JNK activation
通过 FLIPs 下调和 JNK 激活,吞噬作用相关的氧化应激导致细胞凋亡
DOI:
--
发表时间:
2007
期刊:
Journal of Leukocyte Biology 82(11)
影响因子:
--
作者:
[Atsuhiro Kanayama, Yusei Miyamoto]
通讯作者:
Yusei Miyamoto
Taurine is involved in oxidation of IKBcL at Met45.
牛磺酸参与 IKBcL 在 Met45 处的氧化。
DOI:
--
发表时间:
2003
期刊:
Met45. Advances in Experimental Medicine and Biology(Tme 5) 526
影响因子:
--
作者:
[Yusei Miyamoto, Atsuhiro Kanayama, Jun-Ichiro Inoue, Yoshiko Sugita-Konishi Makoto Shimizu.]
通讯作者:
Yoshiko Sugita-Konishi Makoto Shimizu.
Physiological significance of taurine chloramine induced inhibition of NF-_KB activation
-
批准号:12660112
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2000
-
负责人:MIYAMOTO Yusei
-
依托单位:
国内基金
海外基金
登录
查看更多内容
尿毒清颗粒通过调控肠道菌群介导代谢产物-IκB/NF-κB信号轴抗肾间质纤维化机制研究
-
批准号:HZSZ25H270002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:赵英永
-
依托单位:
BGN通过TLR2/IκBζ信号诱导Kupffer细胞脂代谢重编程促进肝癌免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:罗放
-
依托单位:
FOXP4-AS1 通过 IκBα/NF-κB/GTF2I 信号轴诱导结肠
癌细胞对奥沙利铂耐药的机制研究
-
批准号:2024JJ6607
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:金龙
-
依托单位:
ROS介导的半胱次磺酸化修饰调控巨噬细胞IκBζ蛋白稳定促进IBD黏膜炎症机制研究
-
批准号:82300605
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘丹
-
依托单位:
姜黄素纳米颗粒通过靶向结合IκB激酶逆转由肿瘤浸润性B淋巴细胞介导的结直肠肿瘤奥沙利铂耐药的作用及机制
-
批准号:82304974
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:尚玉茹
-
依托单位:
基于Siglec-1/IκBα信号通路的中药小分子物质筛选及其抗COPD炎症反应作用机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:李森森
-
依托单位:
基于ROCK介导IKK/NF-κB/IκB信号通路探讨真武汤促脾肾阳虚型糖尿病肾病炎症消退的分子机制
-
批准号:82160865
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2021
-
负责人:刘臻华
-
依托单位:
PR3通过IκBα蛋白剪切促进急性髓系白血病细胞增殖的分子机制研究
-
批准号:82100156
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:王鸣明
-
依托单位:
葡萄糖通过下调PKA与IκB的互作抑制鹅肥肝中炎症发生的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:龚道清
-
依托单位:
眼葡萄膜黑色素瘤细胞源性外泌体miR-155经巨噬细胞IκBα/NF-κB通路构建肝转移前炎性微环境的作用及机制研究
-
批准号:82003794
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:郑磊
-
依托单位: